Literature DB >> 8241109

Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

I Juhan-Vague1, S G Thompson, J Jespersen.   

Abstract

Hyperinsulinemia, a major indicator of insulin resistance, may exert its influence on the risk of coronary artery disease partially through disturbances of the hemostatic system. The relations of fasting insulin concentrations with the degree of coronary atherosclerosis, other coronary risk factors (including some markers of the insulin resistance syndrome such as body mass index and triglyceride), markers of inflammation, and hemostatic factors were investigated in 1484 patients with angina pectoris. Mean insulin levels were higher in patients with one or more coronary vessel stenoses than in those without (9.9 microU/mL compared with 9.0 microU/mL, P < .0001). However, the association the presence of vessel stenoses was stronger in patients with a previous myocardial infarction than in those without. Insulin increased markedly (P < .0001) and independently of other risk factors with age body mass index, triglyceride concentration, and markers of inflammation, such as white blood cell count and C-reactive protein. The strongest relations between insulin and hemostatic factors were observed with fibrinolytic variables, particularly plasminogen activator inhibitor-1 (PAI-1) levels (r = .44, P < .0001). This relation decreased somewhat (r = .29) after simultaneous adjustment for markers of the insulin resistance syndrome, mainly body mass index and triglycerides, but not after adjustment for markers of inflammation. Therefore, we propose that increased PAI-1 levels, which are essentially related to the classic metabolic aspect of the insulin resistance syndrome, have to be included in this syndrome.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241109     DOI: 10.1161/01.atv.13.12.1865

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  30 in total

Review 1.  The insulin resistance syndrome.

Authors:  Gerald M Reaven
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

2.  Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore.

Authors:  K Hughes; T C Aw; P Kuperan; M Choo
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

Review 3.  Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.

Authors:  Romina M Uranga; Annadora J Bruce-Keller; Christopher D Morrison; Sun Ok Fernandez-Kim; Philip J Ebenezer; Le Zhang; Kalavathi Dasuri; Jeffrey N Keller
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

4.  Is oxidative stress the missing link between insulin resistance and atherosclerosis?

Authors:  A Ceriello; M Pirisi
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

5.  A conceptual framework for predicting and addressing the consequences of disease-related microvascular dysfunction.

Authors:  Penn M McClatchey; Jefferson C Frisbee; Jane E B Reusch
Journal:  Microcirculation       Date:  2017-08       Impact factor: 2.628

Review 6.  Why is initial bacterial colonization of the intestine important to infants' and children's health?

Authors:  Pearl D Houghteling; W Allan Walker
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-03       Impact factor: 2.839

Review 7.  Exercise and diet in the prevention and control of the metabolic syndrome.

Authors:  R J Barnard; S J Wen
Journal:  Sports Med       Date:  1994-10       Impact factor: 11.136

Review 8.  Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease.

Authors:  G M Reaven; A Laws
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

9.  In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction.

Authors:  Barbara Eržen; Mišo Šabovič
Journal:  Heart Vessels       Date:  2012-09-22       Impact factor: 2.037

Review 10.  Insulin resistance and the metabolic syndrome--or the pitfalls of epidemiology.

Authors:  J S Yudkin
Journal:  Diabetologia       Date:  2007-06-26       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.